Everwell Health acquires Celadrin to strengthen joint and skincare innovation

Everwell Health has expanded its portfolio of functional ingredients with the acquisition of the Celadrin brand and its proprietary cetylated fatty acid technology from Things of That Nature, Inc. The acquisition strengthens the company’s presence in the supplement, pet wellness, and cosmetic markets by adding a clinically studied ingredient known for supporting joint comfort, increased mobility, and skin health. As demand for scientifically backed wellness solutions rises, Everwell Health aims to leverage Celadrin’s research-driven formulations to develop new products that align with evolving consumer needs.

Strategic Acquisition to Drive Innovation in Functional Ingredients

The acquisition includes all assets and rights associated with Celadrin, a globally recognized ingredient formulated with esterified fatty acid compounds. It has been widely used in dietary supplements, topical skincare applications, and pet wellness products due to its ability to support joint comfort and increased mobility while also improving skin health. By adding this ingredient to its portfolio, Everwell Health seeks to reinforce its position as a leader in science-driven functional ingredients.

Everwell Health, through its subsidiary Nutrition21, has been focused on developing ingredients with clinically proven benefits. With Celadrin’s well-documented research history, the company is positioned to introduce new formulations that cater to both human and animal health markets. Industry experts note that the integration of Celadrin into Everwell Health’s platform could lead to enhanced product formulations that deliver tangible health benefits.

The science behind Celadrin has been demonstrated in nearly a dozen clinical studies, which have shown that it effectively modulates the body’s natural inflammatory response. Its ability to support cell membrane function has made it a sought-after ingredient in supplements for joint comfort and increased mobility, particularly among individuals looking for non-pharmaceutical alternatives to support an active lifestyle. Additionally, its role in promoting skin health through topical application has made it a valuable ingredient in cosmetic formulations.

Consumer Demand for Mobility and Skin Health Fuels Growth

The acquisition comes at a time when consumer preferences are shifting toward proactive health and wellness solutions. The functional ingredient sector has experienced significant growth, particularly in the areas of joint comfort, increased mobility, and skin health. Market research indicates that joint health supplement launches have increased substantially in recent years, reflecting a growing awareness of mobility support among consumers of all ages. Similarly, the demand for skincare products that promote healthy aging has surged, with consumers actively seeking scientifically supported solutions.

Industry data suggests that more than half of consumers are interested in mobility-supporting products even before experiencing symptoms, highlighting a preventive approach to wellness. At the same time, a significant portion of the market is looking for skincare solutions that visibly reduce the signs of aging. The increasing demand for functional ingredients in both the supplement and beauty industries presents a substantial opportunity for Everwell Health to introduce new formulations that cater to these growing needs.

Expanding Market Presence and Scientific Investment

Celadrin is already sold and marketed in more than a dozen countries, and Everwell Health intends to expand its market reach while ensuring continuity for existing customers. The company plans to invest in further scientific research to explore additional applications of Celadrin and strengthen its position as a trusted ingredient in the supplement, pet wellness, and cosmetic industries.

Everwell Health’s commitment to scientific validation has been a key factor in its expansion strategy. The company aims to leverage Celadrin’s clinical research to support new product development, ensuring that future formulations meet the highest standards of efficacy and safety. As the market for functional ingredients continues to evolve, Everwell Health is focused on driving innovation through evidence-based solutions.

The acquisition of Celadrin aligns with Everwell Health’s broader mission to develop science-backed ingredients that support overall well-being. With a growing emphasis on joint comfort, increased mobility, and skin health, the company is well-positioned to address consumer demands for high-quality, effective wellness solutions.

Future Outlook for Functional Ingredient Innovation

As Everwell Health integrates Celadrin into its portfolio, the company is expected to focus on expanding its applications beyond traditional supplement formulations. The increasing interest in functional foods and beverages presents an opportunity to introduce Celadrin into new delivery formats that align with consumer preferences. Additionally, the rise of personalized nutrition and targeted wellness solutions may drive further innovation in product development.

The acquisition of Celadrin underscores Everwell Health’s commitment to advancing the functional ingredient sector through scientific investment and strategic expansion. By prioritizing research-driven solutions, the company aims to enhance its offerings in joint comfort, increased mobility, and skin health, reinforcing its position as a leader in the industry.